The goals of this trial are to determine if coenzyme Q10 is effective in slowing the
worsening symptoms of Huntington's disease and to learn about the safety and acceptability of
long-term coenzyme Q10 use by determining its effects on people with Huntington's disease.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) University of Rochester